X0306 4 2013-09-10 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001442002 EPIC PHARMA LLC 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 0 0 1 0 Common Stock 2013-09-10 4 C 0 65843621 0.0243 A 74851833 I see footnote Series E Convertible Preferred Stock 0.0243 2013-09-10 4 C 0 1600 0 D Common Stock 65843621 0 I see footnote The reporting person, Epic Pharma, LLC ("EP") owns 100% of the outstanding equity interests, is an equity owner of Epic Investments, LLC ("EI"). The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. Conversion of Series E Preferred Stock of issuer at a rate of approximately 41,152.26 shares of common stock for each share of such preferred stock. The Series E Preferred Stock was convertible at any time and had no expiration date. Ram Potti, Managing Member 2013-09-18